Benutzer: Gast  Login
Titel:

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

Dokumenttyp:
Journal Article
Autor(en):
Roberts, G; Pfaar, O; Akdis, C A; Ansotegui, I J; Durham, S R; Gerth van Wijk, R; Halken, S; Larenas-Linnemann, D; Pawankar, R; Pitsios, C; Sheikh, A; Worm, M; Arasi, S; Calderon, M A; Cingi, C; Dhami, S; Fauquert, J L; Hamelmann, E; Hellings, P; Jacobsen, L; Knol, E F; Lin, S Y; Maggina, P; Mösges, R; Oude Elberink, J N G; Pajno, G B; Pastorello, E A; Penagos, M; Rotiroti, G; Schmidt-Weber, C B; Timmermans, F; Tsilochristou, O; Varga, E-M; Wilkinson, J N; Williams, A; Zhang, L; Agache, I; Angie...     »
Abstract:
Allergic rhinoconjunctivitis (AR) is an allergic disorder of the nose and eyes affecting about a fifth of the general population. Symptoms of AR can be controlled with allergen avoidance measures and pharmacotherapy. However, many patients continue to have ongoing symptoms and an impaired quality of life; pharmacotherapy may also induce some side-effects. Allergen immunotherapy (AIT) represents the only currently available treatment that targets the underlying pathophysiology, and it may have a...     »
Zeitschriftentitel:
Allergy
Jahr:
2018
Band / Volume:
73
Heft / Issue:
4
Seitenangaben Beitrag:
765-798
Sprache:
eng
Volltext / DOI:
doi:10.1111/all.13317
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/28940458
Print-ISSN:
0105-4538
TUM Einrichtung:
Molekulare Allergologie (Prof. Schmidt-Weber)
 BibTeX